Zepp Health Corporation
ZEPP
$4.40
-$0.44-9.09%
NYSE
| 12/31/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 181.18M | 182.65M | 206.12M | 246.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 181.18M | 182.65M | 206.12M | 246.77M |
| Cost of Revenue | -- | 111.29M | 112.40M | 128.96M | 158.68M |
| Gross Profit | -- | 69.90M | 70.25M | 77.16M | 88.08M |
| SG&A Expenses | -- | 74.50M | 71.31M | 68.58M | 66.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 230.90M | 229.84M | 243.74M | 270.47M |
| Operating Income | -- | -49.72M | -47.18M | -37.62M | -23.70M |
| Income Before Tax | -- | -67.02M | -62.04M | -37.21M | -23.62M |
| Income Tax Expenses | -- | 13.73M | 13.69M | 2.89M | 2.96M |
| Earnings from Continuing Operations | -- | -80.75 | -75.74 | -40.10 | -26.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 43.00K | 75.20K | 35.20K | 54.20K |
| Net Income | -- | -80.71M | -75.66M | -40.07M | -26.52M |
| EBIT | -- | -49.72M | -47.18M | -37.62M | -23.70M |
| EBITDA | -- | -43.34M | -40.17M | -29.94M | -15.95M |
| EPS Basic | -- | -80.19 | -74.98 | -39.64 | -26.20 |
| Normalized Basic EPS | -- | -1.03 | -1.68 | -1.06 | -0.53 |
| EPS Diluted | -- | -80.19 | -75.10 | -40.91 | -27.53 |
| Normalized Diluted EPS | -- | -1.03 | -1.68 | -1.06 | -0.53 |
| Average Basic Shares Outstanding | -- | 64.53M | 64.72M | 63.74M | 62.79M |
| Average Diluted Shares Outstanding | -- | 4.03M | 4.04M | 3.98M | 3.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |